EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring the Potential and Advancements of Circular RNA Therapeutics

Lei Wang, Lianqing Wang, Chunbo Dong, Jialong Liu, Guoxin Cui, Shan Gao, Zhida Liu iD

Exploration · 2025-08 · 5 (4)

DOI: 10.1002/exp.20240044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Exploration, 2025-05. Verfasst von Lei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Academy of Advanced Research and Innovation Taiyuan China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) technology is revolutionizing the pharmaceutical industry owing to its superior safety profile, manufacturing capabilities, and potential applications in previously undruggable therapeutic targets. In addition to linear mRNA, such as conventional mRNA, self‐amplifying mRNA, and trans‐amplifying mRNA, circular mRNA has emerged as a promising candidate. Circular RNA (circRNA) is a class of single‐stranded RNA with a covalently closed loop structure that offers enhanced stability compared to linear RNA by resisting degradation from RNases. Recent studies have revolutionized our understanding of their biological functions, surpassing the notion that they are merely byproducts of aberrant splicing events. Given the remarkable success achieved in cancer and SARS‐CoV‐2/monkeypox virus (MPXV) vaccines, circRNA is being intensively investigated for gene and cell therapies. In this review, we provide an overview of circRNA biogenesis mechanisms in vivo, along with synthesis strategies in vitro, while discussing translation regulation mechanisms and quality control processes involved in circRNA production. Furthermore, we explore the potential application scenarios for circRNAs.

Schlagwörter

Stichwörter der Autor:innen

IRESback‐splicingcircRNAmRNAribozymetherapeutics

Autor:innen und Institutionen

  • Shanxi Academy of Advanced Research and Innovation Taiyuan China.
  • MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention Shanxi Medical University Taiyuan China.
  • Department of Biochemistry and Molecular Biology Shanxi Key Laboratory of Birth Defect and Cell Regeneration College of Basic Medical Sciences Shanxi Medical University Taiyuan China.
  • Center of Translational Medicine Zibo Central Hospital Zibo China.
  • College of Veterinary Medicine Shanxi Agricultural University Jinzhong China.
  • Red Sea Research Center Biological and Environmental Science and Engineering Division King Abdullah University of Science and Technology (KAUST) Thuwal Saudi Arabia.

ORCID-Profile: Zhida Liu

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, L., Wang, L., Dong, C., Liu, J., Cui, G., Gao, S., & Liu, Z. (2025). Exploring the Potential and Advancements of Circular RNA Therapeutics. Exploration, 5(4). https://doi.org/10.1002/exp.20240044

Vancouver

Wang L, Wang L, Dong C, Liu J, Cui G, Gao S, et al. Exploring the Potential and Advancements of Circular RNA Therapeutics. Exploration. 2025;5(4). doi:10.1002/exp.20240044

BibTeX
@article{Wang2025,
  author = {Wang, Lei and Wang, Lianqing and Dong, Chunbo and Liu, Jialong and Cui, Guoxin and Gao, Shan and Liu, Zhida},
  title = {Exploring the Potential and Advancements of Circular RNA Therapeutics},
  journal = {Exploration},
  year = {2025},
  volume = {5},
  number = {4},
  doi = {10.1002/exp.20240044}
}
Kostenlos starten →